Chao Yang (Max), PhD, MSc,. BMED
Assistant Professor:State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research
Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine. (Oct.7 2022-till now)
Dr. Chao (Max) Yang starts his lab as an assistant Professor in Oct. 2022 at State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, China. Max finished his PhD in 2018 at the Peter Doherty Institute for Infection and Immunity at the University of Melbourne, where he studied the anti-bacterial activity of interferon gamma in the control of Legionella pneumophila infection. After, he moved to New York and joined professor Lionel Ivashkiv lab, Hospital for Special Surgery, Weill Cornell Medicine. Max has continued his interest in cytokine signaling and investigated the regulation of nucleic acid-sensing TLR8 signaling by CXCL4, previously established as a chemokine and implicated in inflammatory and fibrotic responses, with one paper published in Nature Communications and others under revision at high profile journals. Dr. Yang is also a co-first author on a collaborative paper with the Barrat lab from Hospital for Special Surgery that described plasmacytoid-IFN-macrophage crosstalk relevant for cytokine storm in COVID-19 and has been published in Science Immunology. Max is highly personable and is outgoing and interactive, has initiated collaborations with other scientists, and has been a model lab citizen during his training.
Oral Presentation at Cytokines 2023 in Athens, Greece:
CXCL4 SYNERGIZES WITH TLR8 FOR TBK1-IRF5 ACTIVATION, EPIGENOMIC REMODELING AND INFLAMMATORY RESPONSE IN HUMAN MONOCYTES